Publicaciones en colaboración con investigadores/as de University of South Florida (16)

2023

  1. Measuring DNA modifications with the comet assay: a compendium of protocols

    Nature Protocols, Vol. 18, Núm. 3, pp. 929-989

2022

  1. ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma

    Transplantation and Cellular Therapy, Vol. 28, Núm. 6, pp. 284-293

  2. Trial of Prasinezumab in Early-Stage Parkinson's Disease

    New England Journal of Medicine, Vol. 387, Núm. 5, pp. 421-432

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. The p.E152K-STIM1 mutation deregulates Ca2+ signaling contributing to chronic pancreatitis

    Journal of Cell Science, Vol. 134, Núm. 3

2020

  1. Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?

    Trends in Cancer, Vol. 6, Núm. 3, pp. 181-191

  2. Minimum Information for Reporting on the Comet Assay (MIRCA): recommendations for describing comet assay procedures and results

    Nature Protocols, Vol. 15, Núm. 12, pp. 3817-3826

2019

  1. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study

    The Lancet Oncology, Vol. 20, Núm. 3, pp. 448-458

2018

  1. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials

    JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677

  2. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach

    Value in Health, Vol. 21, Núm. 5, pp. 596-604

2017

  1. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

    Oncogene, Vol. 36, Núm. 19, pp. 2737-2749

2015

  1. COPD comorbidities network

    European Respiratory Journal, Vol. 46, Núm. 3, pp. 640-650

  2. The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes

    Blood Cancer Journal, Vol. 5

2012

  1. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine, Vol. 186, Núm. 2, pp. 155-161

2009

  1. Women with chronic obstructive pulmonary disease: An emerging phenotype of the disease

    Therapy, Vol. 6, Núm. 6, pp. 821-830

2003

  1. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group

    British Journal of Haematology, Vol. 121, Núm. 5, pp. 749-757